Cargando…

3D‐Epigenomic Regulation of Gene Transcription in Hepatocellular Carcinoma

The fundamental cause of transcription dysregulation in hepatocellular carcinoma (HCC) remains elusive. To investigate the underlying mechanisms, comprehensive 3D‐epigenomic analyses are performed in cellular models of THLE2 (a normal hepatocytes cell line) and HepG2 (a hepatocellular carcinoma cell...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Yuliang, Wang, Ping, Cai, Liuyang, Zhan, Meixiao, He, Fan, Wang, Jiahui, Li, Yong, Gega, Eva, Zhang, Wei, Zhao, Wei, Xin, Yongjie, Chen, Xudong, Ruan, Yijun, Lu, Ligong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9993472/ https://www.ncbi.nlm.nih.gov/pubmed/36911294 http://dx.doi.org/10.1002/ggn2.202100010

Ejemplares similares

SUMO1 modification of methyltransferase-like 3 promotes tumor progression via regulating Snail mRNA homeostasis in hepatocellular carcinoma
por: Xu, Hongfa, et al.
Publicado: (2020)

Hypoxia-degradable and long-circulating zwitterionic phosphorylcholine-based nanogel for enhanced tumor drug delivery
por: Peng, Shaojun, et al.
Publicado: (2021)

Distinct binding pattern of EZH2 and JARID2 on RNAs and DNAs in hepatocellular carcinoma development
por: Wen, Zhili, et al.
Publicado: (2022)

Identification of hub genes in hepatocellular carcinoma using integrated bioinformatic analysis
por: Hua, Shengni, et al.
Publicado: (2020)

Zinc finger protein 703 induces EMT and sorafenib resistance in hepatocellular carcinoma by transactivating CLDN4 expression
por: Wang, Hao, et al.
Publicado: (2020)

miR-125b-5p inhibits cell proliferation, migration, and invasion in hepatocellular carcinoma via targeting TXNRD1
por: Hua, Shengni, et al.
Publicado: (2019)

Bidirectional modulation of insulin action by reactive oxygen species in 3T3-L1 adipocytes
por: Ma, Mingfeng, et al.
Publicado: (2018)

ChIA-PIPE: A fully automated pipeline for comprehensive ChIA-PET data analysis and visualization
por: Lee, Byoungkoo, et al.
Publicado: (2020)

Drug resistance mechanism of kinase inhibitors in the treatment of hepatocellular carcinoma
por: Jiang, Lei, et al.
Publicado: (2023)

The Combination Immunotherapy of TLR9 Agonist and OX40 Agonist via Intratumoural Injection for Hepatocellular Carcinoma
por: Zhou, Zhimei, et al.
Publicado: (2021)

Prognostic analysis of tumor mutation burden and immune infiltration in hepatocellular carcinoma based on TCGA data
por: Liu, Shaoqing, et al.
Publicado: (2021)

Self‐Splittable Transcytosis Nanoraspberry for NIR‐II Photo‐Immunometabolic Cancer Therapy in Deep Tumor Tissue
por: Wang, Li, et al.
Publicado: (2022)

Chromatin topology reorganization and transcription repression by PML-RARα in acute promyeloid leukemia
por: Wang, Ping, et al.
Publicado: (2020)

Usp7 regulates Hippo pathway through deubiquitinating the transcriptional coactivator Yorkie
por: Sun, Xiaohan, et al.
Publicado: (2019)

Interactome analysis of gene expression profiles identifies CDC6 as a potential therapeutic target modified by miR-215-5p in hepatocellular carcinoma
por: Xu, Hongfa, et al.
Publicado: (2020)

CXCL12 and IL7R as Novel Therapeutic Targets for Liver Hepatocellular Carcinoma Are Correlated With Somatic Mutations and the Tumor Immunological Microenvironment
por: He, Ke, et al.
Publicado: (2020)

Drug-Eluting Bead Transarterial Chemoembolization Combined with FOLFOX-Based Hepatic Arterial Infusion Chemotherapy for Large or Huge Hepatocellular Carcinoma
por: Huang, Jingjun, et al.
Publicado: (2021)

PLOD2 regulated by transcription factor FOXA1 promotes metastasis in NSCLC
por: Du, Hongzhi, et al.
Publicado: (2017)

POPDC3 is a potential biomarker for prognosis and radioresistance in patients with head and neck squamous cell carcinoma
por: He, Xu, et al.
Publicado: (2019)

LncRNA HOXA11‐AS promotes hepatocellular carcinoma progression by repressing miR‐214‐3p
por: Zhan, Meixiao, et al.
Publicado: (2018)

ChIATAC is an efficient strategy for multi-omics mapping of 3D epigenomes from low-cell inputs
por: Chai, Haoxi, et al.
Publicado: (2023)

Dual‐Cascade Activatable Nanopotentiators Reshaping Adenosine Metabolism for Sono‐Chemodynamic‐Immunotherapy of Deep Tumors
por: Zhan, Meixiao, et al.
Publicado: (2023)

TMSB4X: A novel prognostic marker for non-small cell lung cancer
por: Yang, Ze, et al.
Publicado: (2023)

Extracellular matrix-degrading STING nanoagonists for mild NIR-II photothermal-augmented chemodynamic-immunotherapy
por: Zhan, Meixiao, et al.
Publicado: (2022)

A network of epigenomic and transcriptional cooperation encompassing an epigenomic master regulator in cancer
por: Wilson, Stephen, et al.
Publicado: (2018)

Near-infrared light-triggered nano-prodrug for cancer gas therapy
por: Liu, Runcong, et al.
Publicado: (2021)

Regulation of Age-related Decline by Transcription Factors and Their Crosstalk with the Epigenome
por: Zhou, Xin, et al.
Publicado: (2018)

Single cell epigenomic and transcriptomic analysis uncovers potential transcription factors regulating mitotic/meiotic switch
por: Zhang, Fa-Li, et al.
Publicado: (2023)

Lysyl oxidase-like 3 restrains mitochondrial ferroptosis to promote liver cancer chemoresistance by stabilizing dihydroorotate dehydrogenase
por: Zhan, Meixiao, et al.
Publicado: (2023)

The Transcriptional and Epigenomic Foundations of Ground State Pluripotency
por: Marks, Hendrik, et al.
Publicado: (2012)

Illuminating microRNA Transcription from the Epigenome
por: Sethupathy, Praveen
Publicado: (2013)

From transcriptional regulation to drugging the cancer epigenome
por: Bradner, James E
Publicado: (2014)

Nuclear Functions of TOR: Impact on Transcription and the Epigenome
por: Laribee, R. Nicholas, et al.
Publicado: (2020)

Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells
por: Hou, Xiaoying, et al.
Publicado: (2022)

Sepiapterin reductase promotes hepatocellular carcinoma progression via FoxO3a/Bim signaling in a nonenzymatic manner
por: Wu, Yao, et al.
Publicado: (2020)

Understanding Variation in Transcription Factor Binding by Modeling Transcription Factor Genome-Epigenome Interactions
por: Chen, Chieh-Chun, et al.
Publicado: (2013)

Conservation and divergence of transcriptomic and epigenomic variation in maize hybrids
por: He, Guangming, et al.
Publicado: (2013)

Integrative epigenomic and genomic filtering for methylation markers in hepatocellular carcinomas
por: Shen, Jing, et al.
Publicado: (2015)

An Integrative Genomic and Epigenomic Approach for the Study of Transcriptional Regulation
por: Figueroa, Maria E., et al.
Publicado: (2008)

Integrative Epigenomic Analysis of Transcriptional Regulation of Human CircRNAs
por: Li, Xue-Cang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4n8qish5ibteo99623ao29r7j2